Cara Therapeutics, Inc. (0HTC.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 118.63M |
| Enterprise Value | 98.1M |
| P/E Ratio | -2.06 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.12 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.72 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.6 |
| Return On Equity | -0.64 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -95,000 |
| EBITDA | -26.65M |
| Net Income | -18.21M |
| Diluted EPS | -3.26 |
Balance Sheet
| Total Cash | 24.98M |
| Total Cash/Share | 2.66 |
| Total Debt | 174,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.25 |
| Book Value Per Share | 1.55 |
Price History
| 52-Week Change | 359.48 |
| 52-Week High | 15.99 |
| 52-Week Low | 0.5 |
| Moving Average 50 Days | 0.69 |
| Moving Average 200 Days | 1.89 |
Statistics
| Average Volume | 18,632 |
| Shares Outstanding | 1.52M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 83333:1000000 |
| Last Split Date | December 31, 2024 |
AD
